한글목차

세계의 HLA 타이핑 시장은 2024년에 19억 2,000만 달러로 평가되며, 2030년까지 CAGR 6.50%로 성장하며, 28억 달러에 달할 것으로 예측됩니다. 인간 백혈구 항원(HLA) 타이핑은 이식 수술에서 기증자와 수혜자의 적합성을 판단하고 질병 소인을 평가하기 위해 특정 HLA 대립유전자 또는 대립유전자 그룹을 식별하는 과정입니다. 시장 확대는 주로 장기 및 조혈모세포 이식에 대한 세계 수요 증가와 HLA 분석의 정확성과 효율성을 높이는 분자진단 기술의 지속적인 발전으로 지원되고 있습니다.

주요 시장 성장 촉진요인

장기 및 줄기세포 이식에 대한 수요 증가는 전 세계 인간 백혈구 항원(HLA) 타이핑 시장을 크게 견인하고 있습니다. 생명을 살리는 이식이 필요한 환자 수가 증가함에 따라 이식 거부반응을 예방하고 환자의 치료 결과를 개선하기 위해 정확한 HLA 매칭의 중요성이 점점 더 커지고 있습니다.

주요 시장 과제

시장 발전의 큰 과제는 첨단 고해상도 인간 백혈구 항원(HLA) 타이핑 기술의 도입과 그 운영에 필수적인 전문 인프라를 유지하기 위해 많은 자본 투자가 필요하다는 점입니다. 이러한 막대한 자금 부담은 많은 검사기관의 진입 및 업그레이드 장벽으로 작용하여 세계 HLA 타이핑 시장 확대를 직접적으로 저해하고 있습니다.

주요 시장 동향

실험실 자동화와 하이스루풋 시스템의 보급은 업무 효율성의 중요한 전환점입니다. 이러한 추세는 복잡한 워크플로우를 간소화하고 수작업을 줄임으로써 신속하고 정확한 HLA 타이핑에 대한 수요 증가에 대응하고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 HLA 타이핑 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 기술별(분자 어세이, 시퀀스 기반 분자 어세이, 비분자 어세이)
  • 용도별(진단, 조사)
  • 제품별(기기, 시약·소모품, 소프트웨어·서비스)
  • 최종사용자별(상업 서비스 프로바이더, 병원 및 이식 센터, 연구기관 및 학술기관)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 HLA 타이핑 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 HLA 타이핑 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 HLA 타이핑 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 HLA 타이핑 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 HLA 타이핑 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병·인수
• 제품 출시
• 최근 동향

제13장 세계의 HLA 타이핑 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Qiagen LLC
• Omixon Inc.
• GenDx Products Inc.
• Illumina Inc.
• TBG Diagnostics Limited
• Becton, Dickinson and Company
• Takara Bio USA, Inc.
• F. Hoffman-La Roche Limited

제16장 전략적 제안

제17장 조사회사 소개·면책사항

영문목차

The Global HLA Typing Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.80 Billion by 2030. Human Leukocyte Antigen (HLA) typing constitutes the process of identifying specific HLA alleles or groups of alleles to determine compatibility between donors and recipients in transplantation procedures and for assessing disease predisposition. The market's expansion is primarily supported by the increasing global demand for organ and hematopoietic stem cell transplantation, coupled with continuous advancements in molecular diagnostic techniques that enhance the precision and efficiency of HLA analysis.

Key Market Drivers

The increasing demand for organ and stem cell transplantation significantly drives the global Human Leukocyte Antigen typing market. As the number of patients requiring life-saving transplants grows, the critical need for precise HLA matching intensifies to prevent graft rejection and improve patient outcomes. This necessitates extensive HLA typing services for both recipients and an expanding donor pool.

Key Market Challenges

A substantial challenge for market development lies in the significant capital investment required for adopting advanced, high-resolution Human Leukocyte Antigen (HLA) typing technologies and maintaining the specialized infrastructure essential for their operation. This substantial financial outlay directly hampers the expansion of the global HLA typing market by creating considerable barriers to entry and upgrade for many laboratories. Establishing and equipping facilities with next-generation sequencing platforms and the necessary bioinformatics capabilities demands considerable upfront capital, which smaller institutions or those in regions with limited healthcare budgets often cannot afford.

Key Market Trends

The widespread adoption of laboratory automation and high-throughput systems represents a significant shift in operational efficiency. This trend addresses the increasing demand for rapid and precise HLA typing by streamlining complex workflows and reducing manual intervention. Automation enables laboratories to process a larger volume of samples with improved consistency, which is crucial for managing extensive donor registries and urgent transplant cases.

Key Market Players

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Qiagen LLC
• Omixon Inc.
• GenDx Products Inc.
• Illumina Inc.
• TBG Diagnostics Limited
• Becton, Dickinson and Company
• Takara Bio USA, Inc.
• F. Hoffman-La Roche Limited

Report Scope:

In this report, the Global HLA Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

HLA Typing Market, By Technique:

• Molecular Assay
• Sequenced-based Molecular Assay
• Non-Molecular Assay

HLA Typing Market, By Application:

• Diagnosis
• Research

HLA Typing Market, By Product:

• Instruments
• Reagents & Consumables
• Software & Services

HLA Typing Market, By End User:

• Commercial Service Providers
• Hospitals and Transplant Centers
• Research Labs & Academic Institutes

HLA Typing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global HLA Typing Market.

Available Customizations:

Global HLA Typing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global HLA Typing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Molecular Assay, Sequenced-based Molecular Assay, Non-Molecular Assay)
  • 5.2.2. By Application (Diagnosis, Research)
  • 5.2.3. By Product (Instruments, Reagents & Consumables, Software & Services)
  • 5.2.4. By End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Labs & Academic Institutes)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America HLA Typing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Application
  • 6.2.3. By Product
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States HLA Typing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada HLA Typing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico HLA Typing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe HLA Typing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Application
  • 7.2.3. By Product
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany HLA Typing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. France HLA Typing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom HLA Typing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy HLA Typing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain HLA Typing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia Pacific HLA Typing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Application
  • 8.2.3. By Product
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China HLA Typing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India HLA Typing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan HLA Typing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea HLA Typing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia HLA Typing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. Middle East & Africa HLA Typing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Application
  • 9.2.3. By Product
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia HLA Typing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE HLA Typing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa HLA Typing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. South America HLA Typing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Application
  • 10.2.3. By Product
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil HLA Typing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia HLA Typing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina HLA Typing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global HLA Typing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories Inc.
• 15.3. Qiagen LLC
• 15.4. Omixon Inc.
• 15.5. GenDx Products Inc.
• 15.6. Illumina Inc.
• 15.7. TBG Diagnostics Limited
• 15.8. Becton, Dickinson and Company
• 15.9. Takara Bio USA, Inc.
• 15.10. F. Hoffman-La Roche Limited

16. Strategic Recommendations

17. About Us & Disclaimer